Back

Growth differentiation factor (GDF15) profile and prognostic implications across the left ventricular ejection fraction in chronic heart failure

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - biomarkers 1 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Kanako Teramoto

National Cerebral and Cardiovascular Center Hospital, Osaka (Japan)

7 More presentations in this session

Presentation thumbnail
Biomarkers associated with declining cognitive performance in patients hospitalized for acute heart failure
Doctor A. Yaghoubi (Malmoe, SE)
Abstract Slides Video
Presentation thumbnail
Cardiovascular and renal outcomes related to urinary albumin to creatinine ratio in patients with heart failure and reduced ejection fraction: A pooled analysis of ATMOSPHERE and PARADIGM-HF
Doctor L. Shen (Glasgow, CN)
Abstract Slides Video
Presentation thumbnail
Proteomic biomarkers are linked to QTc interval in patients with chronic heart failure.
Mrs M. Barry-Loncq De Jong (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Clinical and proteomic profiles of chronic kidney disease in heart failure with preserved and reduced ejection fraction
Mr G. Voordes (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Usefulness of CA125 and NT-proBNP for assessing congestion in chronic heart failure. Insights from CARDIOREN registry.
Doctor M. Cobo Marcos (Majadahonda, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - biomarkers 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
The prognostic value of GDF15 in patients with heart failure and coronary artery disease after coronary artery bypass grafting
thumbnail
Congress Presentation
Growth differentiation factor-15 is associated with myocardial infarction and death at 30 and 90 days in ED patients with suspected acute coronary syndrome
thumbnail
Congress Presentation
Growth differentiation factor 15 and all-cause and cause-specific mortality in patients with suspected or known coronary artery disease: The ANOX and EXCEED-J Studies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources